DK500382A - Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf - Google Patents

Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf Download PDF

Info

Publication number
DK500382A
DK500382A DK500382A DK500382A DK500382A DK 500382 A DK500382 A DK 500382A DK 500382 A DK500382 A DK 500382A DK 500382 A DK500382 A DK 500382A DK 500382 A DK500382 A DK 500382A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
DK500382A
Other languages
English (en)
Inventor
David Brown
Rodney Brian Hargreaves
Bernard Joseph Mcloughlin
Stuart Dennett Mills
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of DK500382A publication Critical patent/DK500382A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21Radicals derived from sulfur analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK500382A 1981-11-12 1982-11-10 Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf DK500382A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8134175 1981-11-12

Publications (1)

Publication Number Publication Date
DK500382A true DK500382A (da) 1983-05-13

Family

ID=10525836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK500382A DK500382A (da) 1981-11-12 1982-11-10 Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf

Country Status (14)

Country Link
US (3) US4495185A (da)
EP (1) EP0080296A1 (da)
JP (1) JPS5890567A (da)
AU (1) AU563867B2 (da)
CA (1) CA1199028A (da)
DK (1) DK500382A (da)
ES (1) ES517332A0 (da)
FI (1) FI823894L (da)
GR (1) GR77365B (da)
IL (1) IL67185A0 (da)
NO (1) NO823767L (da)
NZ (1) NZ202472A (da)
PT (1) PT75827B (da)
ZA (1) ZA828304B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
JPS5962578A (ja) * 1982-10-04 1984-04-10 Mitsui Toatsu Chem Inc オキサジアジン誘導体およびそれを含有する医薬組成物
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
JPS59196874A (ja) * 1983-04-22 1984-11-08 Fujisawa Pharmaceut Co Ltd トリアジン誘導体
JPS61106574A (ja) * 1984-10-29 1986-05-24 Yoshitomi Pharmaceut Ind Ltd オキサ(またはチア)ジアジン誘導体
US4782066A (en) * 1985-04-19 1988-11-01 Uniroyal Chemical Company, Inc. Substituted oxadiazinone miticidal compositions and use
DE3631085A1 (de) * 1986-09-12 1988-03-24 Boehringer Mannheim Gmbh Heterocyclisch substituierte indolinone, verfahren zu ihrer herstellung, arzneimittel sowie zwischenprodukte
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
HU209473B (en) * 1990-12-22 1994-06-28 Egyt Gyogyszervegyeszeti Gyar Process for production of fodder-additives, premixes and fodders containing n-thiobenzoil-morpholine derivatives with weight-gain increasing action
HU212783B (en) * 1990-12-22 1996-11-28 Egyt Gyogyszervegyeszeti Gyar Process for producing new thiobenzoyl morpholide derivatives and weight increasing agents comprising such compounds
FR2671551B1 (fr) * 1991-01-15 1993-03-12 Adir Nouveaux composes de structure aryl triazinique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE4134893A1 (de) * 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
US5446163A (en) * 1992-10-02 1995-08-29 Reilly Industries, Inc. Preparation of hydrazones, dihydrothiadiazoles and triazinones
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
WO2019025554A1 (en) 2017-08-04 2019-02-07 Bayer Aktiengesellschaft 6-PHENYL-4,5-DIHYDROPYRIDAZIN-3 (2H) -ONE DERIVATIVES AS INHIBITORS OF PDE3A AND PDE3B FOR THE TREATMENT OF CANCER
WO2020157188A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft Dihydrooxadiazinones for the treatment of hyperproliferative diseases
WO2020157201A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft Oxadiazinone compounds for the treatment of hyperproliferative diseases
WO2020157189A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft 1,2,4-triazin-6(1h)-one compounds for the treatment of hyperproliferative diseases
WO2020157194A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft 1,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3377345A (en) * 1966-09-23 1968-04-09 Dow Chemical Co Substituted 3, 4, 5, 6-tetrahydro-2h-1, 3, 4-oxadiazin-2-one compounds and method ofpreparation thereof
US3946010A (en) * 1975-04-09 1976-03-23 E. R. Squibb & Sons, Inc. 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
US4097671A (en) * 1975-08-28 1978-06-27 General Electric Company Dihydrooxadiazinones and method for making
US4105848A (en) * 1976-12-27 1978-08-08 General Electric Company Process for the production of dihydrooxadiazinone compounds
EP0052442B1 (en) * 1980-11-14 1985-09-11 Imperial Chemical Industries Plc Heterocyclic compounds
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
US4489074A (en) * 1982-11-12 1984-12-18 Imperial Chemical Industries, Plc 1,3,4-Thiadiazin-2-ones
JPH072947B2 (ja) * 1985-06-27 1995-01-18 松下電子工業株式会社 螢光体

Also Published As

Publication number Publication date
US4694005A (en) 1987-09-15
US4584298A (en) 1986-04-22
FI823894A0 (fi) 1982-11-12
JPS5890567A (ja) 1983-05-30
ES8404339A1 (es) 1984-04-16
PT75827A (en) 1982-12-01
NZ202472A (en) 1985-11-08
ES517332A0 (es) 1984-04-16
FI823894L (fi) 1983-05-13
PT75827B (en) 1985-11-12
US4495185A (en) 1985-01-22
EP0080296A1 (en) 1983-06-01
AU563867B2 (en) 1987-07-23
AU9038882A (en) 1983-05-19
ZA828304B (en) 1983-09-28
CA1199028A (en) 1986-01-07
NO823767L (no) 1983-05-13
IL67185A0 (en) 1983-03-31
GR77365B (da) 1984-09-11

Similar Documents

Publication Publication Date Title
DK495281A (da) Benzoheterocykliske forbindelser samt fremgangsmaade til fremstilling deraf
DK500382A (da) Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf
DK307883A (da) Carbostyrilderivater samt fremgangsmaade til fremstilling deraf
DK160792C (da) Soedemiddel samt fremgangsmaade til fremstilling deraf
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
DK222382A (da) Benzezepinderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK93383A (da) Glycoproteiner samt fremgangsmaade til fremstilling heraf
DK291180A (da) Indolizinderivater samt fremgangsmaade til fremstilling deraf
DK125485D0 (da) Guaninderivater samt fremgangsmaade til fremstilling heraf
DK173686D0 (da) Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf
DK223180A (da) 3-formylmethylcephalosporiner samt fremgangsmaade til fremstilling heraf
DK353083A (da) Kanyleholderkonstruktion samt fremgangsmaade til fremstilling heraf
DK480384D0 (da) Cephalosporinderivater samt fremgangsmaader til fremstilling deraf
DK121282A (da) Heterocykliske derivater
DK487082A (da) Heterocykliske forbindelser
FI820297L (fi) Anordning foer avklippning av traedstammar
DK364483D0 (da) 14-aminosteroid-derivater samt fremgangsmade til fremstilling deraf
DK115685A (da) Prespap samt fremgangsmaade til fremstilling deraf
FI834289A0 (fi) Medbringare foer en draganordning
DK576482A (da) Aminopropylaminobleomycin-derivater samt fremgangsmaade til fremstilling heraf
FI831957A0 (fi) Anordning foer hantering av storbalar
DK191584D0 (da) Substituerede diphenylazomethinderivater samt fremgangsmaade til fremstilling deraf
DK191684D0 (da) Hydroxylerede diphenylazomethinderivater samt fremgangsmaade til fremstilling deraf
DK458082A (da) 2-isopropylamino-pyrimidin-n-oxid samt fremgangsmaade til fremstilling deraf
DK161193C (da) Modificerede lerarter samt fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment